Evolent Health Inc.

8.51
-0.45 (-5.02%)
At close: Apr 21, 2025, 3:59 PM
8.65
1.65%
After-hours: Apr 21, 2025, 08:00 PM EDT

Evolent Health Statistics

Share Statistics

Evolent Health has 116.59M shares outstanding. The number of shares has increased by 0.33% in one year.

Shares Outstanding 116.59M
Shares Change (YoY) 0.33%
Shares Change (QoQ) 0.02%
Owned by Institutions (%) 99.99%
Shares Floating 113.57M
Failed to Deliver (FTD) Shares 2.01K
FTD / Avg. Volume 0.08%

Short Selling Information

The latest short interest is 15.89M, so 13.63% of the outstanding shares have been sold short.

Short Interest 15.89M
Short % of Shares Out 13.63%
Short % of Float 15.51%
Short Ratio (days to cover) 9.04

Valuation Ratios

The PE ratio is -20.94 and the forward PE ratio is 15.45. Evolent Health's PEG ratio is 0.57.

PE Ratio -20.94
Forward PE 15.45
PS Ratio 0.51
Forward PS 0.3
PB Ratio 1.29
P/FCF Ratio -210.54
PEG Ratio 0.57
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Evolent Health.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.22.

Current Ratio 0.85
Quick Ratio 0.85
Debt / Equity 0.22
Debt / EBITDA 2.79
Debt / FCF -36.42
Interest Coverage -1.64

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $567.72K
Profits Per Employee $-13.69K
Employee Count 4,500
Asset Turnover 1
Inventory Turnover n/a

Taxes

Income Tax -1.41M
Effective Tax Rate 2.24%

Stock Price Statistics

The stock price has increased by -71.5% in the last 52 weeks. The beta is 1.2, so Evolent Health's price volatility has been higher than the market average.

Beta 1.2
52-Week Price Change -71.5%
50-Day Moving Average 9.63
200-Day Moving Average 17.39
Relative Strength Index (RSI) 33.71
Average Volume (20 Days) 2.53M

Income Statement

In the last 12 months, Evolent Health had revenue of 2.55B and earned -61.62M in profits. Earnings per share was -0.81.

Revenue 2.55B
Gross Profit 367.35M
Operating Income -40.48M
Net Income -61.62M
EBITDA 80.06M
EBIT -38.31M
Earnings Per Share (EPS) -0.81
Full Income Statement

Balance Sheet

The company has 104.2M in cash and 223.15M in debt, giving a net cash position of -118.95M.

Cash & Cash Equivalents 104.2M
Total Debt 223.15M
Net Cash -118.95M
Retained Earnings -780.82M
Total Assets 2.54B
Working Capital -108.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.77M and capital expenditures -24.89M, giving a free cash flow of -6.13M.

Operating Cash Flow 18.77M
Capital Expenditures -24.89M
Free Cash Flow -6.13M
FCF Per Share -0.05
Full Cash Flow Statement

Margins

Gross margin is 14.38%, with operating and profit margins of -1.58% and -2.41%.

Gross Margin 14.38%
Operating Margin -1.58%
Pretax Margin -2.47%
Profit Margin -2.41%
EBITDA Margin 3.13%
EBIT Margin -1.58%
FCF Margin -0.24%

Dividends & Yields

EVH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for EVH is $15, which is 76.3% higher than the current price. The consensus rating is "Buy".

Price Target $15
Price Target Difference 76.3%
Analyst Consensus Buy
Analyst Count 14
Stock Forecasts

Scores

Altman Z-Score 0.88
Piotroski F-Score 4